Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prickle planar cell polarity protein 3 (PRICKLE3) is a LIM domain-containing modular protein involved in the core module of the planar cell polarity (PCP) pathway, essential for the polarization of epithelial cells during morphogenesis, including gastrulation and neurulation[3][4][6]. Its three LIM domains mediate protein-protein interactions, enabling complex assembly and signaling. PRICKLE3 localizes to the basal body and is involved in cilia growth, positioning, and cellular organization[1][3][4]. It also plays a role in the assembly and stability of mitochondrial ATP synthase, influencing bioenergetics[2][3][4]. Disease associations include being a genetic modifier in Leber hereditary optic neuropathy and ocular motility disease[3]; however, it is not currently a recognized therapeutic target nor does it directly interact with drugs, nor serve as a clinical biomarker. Disruption of PRICKLE3 impairs cilia-related developmental processes and can affect cell polarity and mitochondrial function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prickle planar cell polarity protein 3 (PRICKLE3).